What is NDC 81481-803?

81481-803 is the product NDC for Anktiva (nogapendekin alfa inbakicept-pmln), Nogapendekin alfa inbakicept-pmln 400 ug/.4mL solution, listed with the FDA by Altor BioScience, LLC, an indirect wholly-owned subsidiary of ImmunityBio, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Anktiva (Nogapendekin alfa inbakicept-pmln).

What is the active ingredient?

Nogapendekin alfa inbakicept-pmln.

Altor BioScience, LLC, an indirect wholly-owned subsidiary of ImmunityBio, Inc., NDC labeler code 81481. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Anktiva?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Anktiva NDC 81481-803 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)81481-803Labeler and product segments. Claims need a package NDC.

Product NDC at billing width81481-0803Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
81481-803-01	81481080301	1 VIAL, GLASS in 1 BOX (81481-803-01) / .4 mL in 1 VIAL, GLASSMarketed from May 6, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Anktiva
Generic name (nonproprietary): nogapendekin alfa inbakicept-pmln
Active ingredients: Nogapendekin alfa inbakicept-pmln — 400 ug/.4mL
Dosage form: Solution
Route: Intravesical
Labeler: Altor BioScience, LLC, an indirect wholly-owned subsidiary of ImmunityBio, Inc.NDC labeler code 81481
Product type: Prescription drug
Marketing category: BLA — Biologics License ApplicationApplication BLA 761336
Marketing start: May 6, 2024
Listing expires: Dec 31, 2026
Other FDA classes: Interleukin-15 Receptor Agonists (Mechanism)
Identifiers: Product ID 81481-803_3851a6cd-d487-2012-e063-6394a90aa33eSPL ID 3851a6cd-d487-2012-e063-6394a90aa33eSPL set ID eae31db8-3e7a-d9e0-708d-74419d1b50ffRxCUI 2682684, 2682691UNII 7TK323DLA0
Pharmacologic class: Interleukin-15 Receptor Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N481481080301 followed by a unit qualifier and the quantity

Package 81481-0803-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 24, 2025.

Indications (excerpt from the label)

ANKTIVA in combination with Bacillus Calmette-Guérin (BCG) is indicated for the treatment of adult patients with BCG-unresponsive nonmuscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) with or without papillary tumors. ANKTIVA is an interleukin-15 (IL-15) receptor agonist indicated with Bacillus Calmette-Guérin (BCG) for the treatment of adult patients with BCG-unresponsive nonmuscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) with or without papillary tumors. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 81481-803

What is NDC 81481-803?: 81481-803 is the product NDC for Anktiva (nogapendekin alfa inbakicept-pmln), Nogapendekin alfa inbakicept-pmln 400 ug/.4mL solution, listed with the FDA by Altor BioScience, LLC, an indirect wholly-owned subsidiary of ImmunityBio, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Anktiva (Nogapendekin alfa inbakicept-pmln).
What is the active ingredient?: Nogapendekin alfa inbakicept-pmln.
Who is the labeler?: Altor BioScience, LLC, an indirect wholly-owned subsidiary of ImmunityBio, Inc., NDC labeler code 81481. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Anktiva?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Anktiva (Nogapendekin alfa inbakicept-pmln) NDC 81481-803